4//SEC Filing
SAPIRSTEIN JAMES 4
Accession 0001493152-24-028403
CIK 0001859007other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 9:35 PM ET
Size
14.9 KB
Accession
0001493152-24-028403
Insider Transaction Report
Form 4
SAPIRSTEIN JAMES
Director
Transactions
- Award
Stock Options
2023-05-24+132→ 132 totalExercise: $152.46Exp: 2033-05-24→ Common Stock (132 underlying)
Footnotes (3)
- [F1]The option disclosed on this Form 4 was not previously reported due to an administrative oversight.
- [F2]Share and dollar amounts give effect to the issuer's 1-for-35 reverse stock split effectuated on December 4, 2023, and 1-for-10 reverse stock split effectuated on April 25, 2024.
- [F3]The option vests annually in three equal installments commencing on May 24, 2024.
Documents
Issuer
ZyVersa Therapeutics, Inc.
CIK 0001859007
Entity typeother
Related Parties
1- filerCIK 0001559509
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 9:35 PM ET
- Size
- 14.9 KB